BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17895302)

  • 1. Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus.
    Barkauskaite V; Ek M; Popovic K; Harris HE; Wahren-Herlenius M; Nyberg F
    Lupus; 2007; 16(10):794-802. PubMed ID: 17895302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus.
    Popovic K; Ek M; Espinosa A; Padyukov L; Harris HE; Wahren-Herlenius M; Nyberg F
    Arthritis Rheum; 2005 Nov; 52(11):3639-45. PubMed ID: 16255056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous lupus erythematosus: recent lessons from animal models.
    Ghoreishi M; Dutz JP
    Lupus; 2010 Aug; 19(9):1029-35. PubMed ID: 20693196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of cutaneous lupus erythematosus.
    Kuhn A; Bijl M
    Lupus; 2008 May; 17(5):389-93. PubMed ID: 18490414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cytokines in the pathogenesis of cutaneous lupus erythematosus.
    Robinson ES; Werth VP
    Cytokine; 2015 Jun; 73(2):326-34. PubMed ID: 25767072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of cutaneous lupus erythematosus--novel aspects.
    Kuhn A; Krammer PH; Kolb-Bachofen V
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii14-6. PubMed ID: 16987823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic and genetic considerations of cutaneous lupus erythematosus: a comprehensive review.
    Yu C; Chang C; Zhang J
    J Autoimmun; 2013 Mar; 41():34-45. PubMed ID: 23380467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjögren's syndrome.
    Ek M; Popovic K; Harris HE; Nauclér CS; Wahren-Herlenius M
    Arthritis Rheum; 2006 Jul; 54(7):2289-94. PubMed ID: 16802368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines.
    Kalinina N; Agrotis A; Antropova Y; DiVitto G; Kanellakis P; Kostolias G; Ilyinskaya O; Tararak E; Bobik A
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2320-5. PubMed ID: 15374849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus.
    Wozniacka A; Lesiak A; Boncela J; Smolarczyk K; McCauliffe DP; Sysa-Jedrzejowska A
    Br J Dermatol; 2008 Nov; 159(5):1124-30. PubMed ID: 18764842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients.
    Reefman E; Kuiper H; Limburg PC; Kallenberg CG; Bijl M
    Ann Rheum Dis; 2008 Jan; 67(1):11-18. PubMed ID: 17502354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photosensitivity, phototesting, and photoprotection in cutaneous lupus erythematosus.
    Kuhn A; Ruland V; Bonsmann G
    Lupus; 2010 Aug; 19(9):1036-46. PubMed ID: 20693197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinflammatory cytokine (IL-1beta, IL-6, IL-12, IL-18 and TNF-alpha) levels in sera of patients with subacute cutaneous lupus erythematosus (SCLE).
    Maczynska I; Millo B; Ratajczak-Stefańska V; Maleszka R; Szych Z; Kurpisz M; Giedrys-Kalemba S
    Immunol Lett; 2006 Jan; 102(1):79-82. PubMed ID: 16154204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis.
    Palmblad K; Sundberg E; Diez M; Söderling R; Aveberger AC; Andersson U; Harris HE
    Arthritis Res Ther; 2007; 9(2):R35. PubMed ID: 17397533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a pathogenetic role of interleukin-18 in cutaneous lupus erythematosus.
    Wang D; Drenker M; Eiz-Vesper B; Werfel T; Wittmann M
    Arthritis Rheum; 2008 Oct; 58(10):3205-15. PubMed ID: 18821674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of cutaneous lupus erythematosus: common and different features in distinct subsets.
    Wenzel J; Zahn S; Tüting T
    Lupus; 2010 Aug; 19(9):1020-8. PubMed ID: 20693195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral lesions in lupus erythematosus-cytokines profiles of inflammatory infiltrate.
    Marques ER; Lourenço SV; Lima DM; Nico MM
    J Cutan Pathol; 2010 Apr; 37(4):439-45. PubMed ID: 19751227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA.
    Wenzel J; Uerlich M; Wörrenkämper E; Freutel S; Bieber T; Tüting T
    Br J Dermatol; 2005 Nov; 153(5):1011-5. PubMed ID: 16225615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of guanylate binding protein-1 in lesional skin of patients with cutaneous lupus erythematosus.
    Naschberger E; Wenzel J; Kretz CC; Herrmann M; Stürzl M; Kuhn A
    Exp Dermatol; 2011 Feb; 20(2):102-6. PubMed ID: 21121962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-18 and skin inflammation.
    Wittmann M; Macdonald A; Renne J
    Autoimmun Rev; 2009 Sep; 9(1):45-8. PubMed ID: 19285156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.